Anne Peretz

2.4k total citations · 1 hit paper
57 papers, 1.8k citations indexed

About

Anne Peretz is a scholar working on Nutrition and Dietetics, Orthopedics and Sports Medicine and Oncology. According to data from OpenAlex, Anne Peretz has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nutrition and Dietetics, 16 papers in Orthopedics and Sports Medicine and 10 papers in Oncology. Recurrent topics in Anne Peretz's work include Trace Elements in Health (15 papers), Bone health and osteoporosis research (15 papers) and Bone and Joint Diseases (6 papers). Anne Peretz is often cited by papers focused on Trace Elements in Health (15 papers), Bone health and osteoporosis research (15 papers) and Bone and Joint Diseases (6 papers). Anne Peretz collaborates with scholars based in Belgium, United States and France. Anne Peretz's co-authors include Jan‐Walter De Neve, Wojciech Wąsowicz, Serge Rozenberg, Jean Nève, P. Bergmann, Muriel Moris, Gregory Gaich, Αλεξάνδρα Παπαϊωάννου, Jean‐Jacques Body and David C. Cumming and has published in prestigious journals such as American Journal of Clinical Nutrition, The Journal of Clinical Endocrinology & Metabolism and Clinical Chemistry.

In The Last Decade

Anne Peretz

56 papers receiving 1.8k citations

Hit Papers

Optimized steps in fluoro... 1993 2026 2004 2015 1993 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Peretz Belgium 20 498 389 333 330 208 57 1.8k
M. Revilla Spain 30 979 2.0× 337 0.9× 310 0.9× 578 1.8× 369 1.8× 145 2.7k
P. H. Whiting United Kingdom 33 208 0.4× 163 0.4× 316 0.9× 545 1.7× 371 1.8× 122 3.0k
S. Shaw United States 19 445 0.9× 370 1.0× 171 0.5× 370 1.1× 310 1.5× 30 2.5k
Pauling Chu Taiwan 23 134 0.3× 191 0.5× 133 0.4× 723 2.2× 198 1.0× 72 1.8k
Madan M. Godbole India 31 162 0.3× 272 0.7× 183 0.5× 977 3.0× 155 0.7× 72 2.4k
Pauli Ylitalo Finland 24 192 0.4× 91 0.2× 389 1.2× 271 0.8× 235 1.1× 140 1.9k
Moncef Feki Tunisia 28 158 0.3× 442 1.1× 120 0.4× 565 1.7× 335 1.6× 253 3.1k
Vincent Ricchiuti United States 23 132 0.3× 133 0.3× 330 1.0× 386 1.2× 449 2.2× 42 2.4k
C. Popp‐Snijders Netherlands 34 558 1.1× 833 2.1× 298 0.9× 654 2.0× 537 2.6× 89 3.9k
Francesca Pagani Italy 24 150 0.3× 354 0.9× 159 0.5× 478 1.4× 376 1.8× 97 2.0k

Countries citing papers authored by Anne Peretz

Since Specialization
Citations

This map shows the geographic impact of Anne Peretz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Peretz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Peretz more than expected).

Fields of papers citing papers by Anne Peretz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Peretz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Peretz. The network helps show where Anne Peretz may publish in the future.

Co-authorship network of co-authors of Anne Peretz

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Peretz. A scholar is included among the top collaborators of Anne Peretz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Peretz. Anne Peretz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malonne, Hugues, et al.. (2005). Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain. Journal of Clinical Pharmacy and Therapeutics. 30(2). 113–120. 32 indexed citations
2.
Peretz, Anne, et al.. (2003). Response to alendronate in osteoporotic women previously treated with pamidronate. Maturitas. 44(2). 111–115. 7 indexed citations
3.
Peretz, Anne, et al.. (2002). Unusual Localisation of Chronic Arthropathy in Lumbar Facet Joints after Parvovirus B19 Infection. Clinical Rheumatology. 21(4). 306–308. 9 indexed citations
4.
Peretz, Anne, et al.. (2002). UVEITIS MANAGEMENT : A MULTIDISCIPLINARY APPROACH TO ASSESS SYSTEMIC INVOLVEMENT AND SIDE EFFECTS OF TREATMENTS. Acta Clinica Belgica. 57(3). 142–147. 6 indexed citations
5.
Henrotin, Yves, Marc Vanderthommen, Jacques Grisart, et al.. (2001). Définition, critères de qualité et évaluation d’un programme de type école du dos. Recommandations de la Société belge des écoles du dos (SBED). Revue du Rhumatisme. 68(2). 185–191. 8 indexed citations
7.
Peretz, Anne, María Moris, Dominique Willems, & P. Bergmann. (1996). Is bone alkaline phosphatase an adequate marker of bone metabolism during acute corticosteroid treatment?. Clinical Chemistry. 42(1). 102–103. 9 indexed citations
8.
Moris, Muriel, et al.. (1995). Quantitative ultrasound bone measurements: Normal values and comparison with bone mineral density by dual X-ray absorptiometry. Calcified Tissue International. 57(1). 6–10. 81 indexed citations
9.
Rozenberg, Serge, Jean Vandromme, Jan‐Walter De Neve, et al.. (1995). Precision and accuracy of in vivo bone mineral measurement in rats using dual-energy X-ray absorptiometry. Osteoporosis International. 5(1). 47–53. 42 indexed citations
10.
Peretz, Anne, et al.. (1993). Zinc distribution in blood components, inflammatory status, and clinical indexes of disease activity during zinc supplementation in inflammatory rheumatic diseases. American Journal of Clinical Nutrition. 57(5). 690–694. 19 indexed citations
11.
Nève, Jean, et al.. (1993). [Some factors influencing the bioavailability of zinc in oral pharmaceutical dosage forms].. PubMed. 48(1). 5–11. 6 indexed citations
12.
Peretz, Anne, et al.. (1992). Effects of selenium supplementation on immune parameters in gut failure patients on home parenteral nutrition.. PubMed. 7(3). 215–21. 27 indexed citations
13.
Fontaine, Jeanine, Jean Nève, Anne Peretz, & Jean-Pierre Famaey. (1992). Effects of acute prednisolone administration on plasma and liver copper in rats with adjuvant arthritis. Biological Trace Element Research. 32(1-3). 355–360. 4 indexed citations
14.
Hanocq, Michel, et al.. (1992). Absorption and metabolism of oral zinc gluconate in humans in fasting state, during, and after a meal. Biological Trace Element Research. 32(1-3). 201–212. 19 indexed citations
15.
Fontaine, Jeanine, Jan‐Walter De Neve, Anne Peretz, P. Capel, & Jean Pierre Famaey. (1991). Effects of acute and chronic prednisolone treatment on serum zinc levels in rats with adjuvant arthritis. Inflammation Research. 33(3-4). 247–253. 11 indexed citations
16.
Peretz, Anne, et al.. (1991). Interest of zinc determination in leucocyte fractions for the assessment of marginal zinc status. Clinica Chimica Acta. 203(1). 35–46. 12 indexed citations
17.
Peretz, Anne, et al.. (1989). Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment.. PubMed. 16(3). 363–7. 41 indexed citations
18.
Rozenberg, Serge, et al.. (1988). Serum levels of gonadotrophins and steroid hormones in the post-menopause and later life. Maturitas. 10(3). 215–224. 43 indexed citations
19.
Rozenberg, Serge, et al.. (1987). Biological profiles of patients with discordances between cortical and trabecular bone mineral contents. Medical science research. 15(18). 1097–1099. 1 indexed citations
20.
Nève, Jean, et al.. (1987). L'importance nutritionnelle du sélénium. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 145–162. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026